---
figid: PMC5819301__13395_2018_150_Fig8_HTML
figtitle: Nilotinib effects on myoblasts and skeletal myogenesis
organisms:
- Bos taurus
- Oryctolagus cuniculus
- Capra hircus
- Equus caballus
- Armoracia rusticana
- Diaporthe sclerotioides
- Homo sapiens
- Mus musculus
- NA
organisms_ner:
- Mus musculus
- Homo sapiens
- Bos taurus
- Drosophila melanogaster
pmcid: PMC5819301
filename: 13395_2018_150_Fig8_HTML.jpg
figlink: /pmc/articles/PMC5819301/figure/Fig8/
number: F8
caption: Model of Nilotinib effects on myoblasts and skeletal myogenesis. Nilotinib
  binds to and inhibits p38 MAPK. Consequently, Nilotinib activates the MEK/ERK proliferation
  signaling inhibiting myoblast differentiation. Simultaneously, Nilotinib stimulates
  the AKT survival pathway. In addition, ERK1/2 and AKT stimulation is required for
  Nilotinib-induced myoblast proliferation. The stimulation of proliferation and the
  anti-myogenic effects of Nilotinib through the perturbation of p38, ERK, and AKT
  signaling pathways are illustrated
papertitle: Nilotinib impairs skeletal myogenesis by increasing myoblast proliferation.
reftext: Osvaldo Contreras, et al. Skelet Muscle. 2018;8:5.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.534567
figid_alias: PMC5819301__F8
figtype: Figure
redirect_from: /figures/PMC5819301__F8
ndex: 62af5dd6-de93-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5819301__13395_2018_150_Fig8_HTML.html
  '@type': Dataset
  description: Model of Nilotinib effects on myoblasts and skeletal myogenesis. Nilotinib
    binds to and inhibits p38 MAPK. Consequently, Nilotinib activates the MEK/ERK
    proliferation signaling inhibiting myoblast differentiation. Simultaneously, Nilotinib
    stimulates the AKT survival pathway. In addition, ERK1/2 and AKT stimulation is
    required for Nilotinib-induced myoblast proliferation. The stimulation of proliferation
    and the anti-myogenic effects of Nilotinib through the perturbation of p38, ERK,
    and AKT signaling pathways are illustrated
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Myog
  - Synpo2
  - Pik3r1
  - Map2k1
  - Mpeg1
  - Crk
  - Grap2
  - Syp
  - Mapk14
  - Ahsa1
  - Akt1
  - Ly20
  - Mapk3
  - Map3k4
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - MAP2K1
  - MPEG1
  - CRK
  - MAPK14
  - MAPK1
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - AKT1
  - AKT2
  - AKT3
  - MAPK3
  - THAS
  - myo
  - sqh
  - Mhc
  - zip
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - lic
  - p38b
  - Nurf-38
  - Ebp
  - p38a
  - Hrb87F
  - p38c
  - Akt
  - rl
  - Nilotinib
---
